Entos Pharmaceuticals

This week at #TIDESUSA, John Lewis, CEO of Entos Pharmaceuticals will present on our Fusogenix Proteo-Lipid Vehicle Drug Delivery Platform, on Thursday, May 16 at 2:30 pm ET. Want to connect? DM John Lewis or CSO Arun Raturi to meet to talk about the next generation of non-viral delivery! #TIDESUSA #OligonucleotidePeptideTherapeutics #EntosSpeaks #Fusogenix #PLVs #nucleicaciddelivery #geneticmedicines #biotechnology

Yesterday was a great day at ASGCT for Entos Pharmaceuticals, CSO Arun Raturi presented his talk on "Durable DNA-Based Gene Therapy Using the Non-Viral Fusogenix Proteolipid Vehicle Platform". We've had great discussions and lots of interest in our next generation nucleic acid delivery platform! Want to continue the conversation? We have a big team from Entos at the conference DM John Lewis, Arun Raturi, Jitendra Kumar, PraKash Bhandari, Douglas Brown, or Amirali Bukhari to meet. #ASGCT2024 #EntosSpeaks #Fusogenix #PLV #geneticmedicines #genetherapy

Last day at ARVO 2024! Entos Pharmaceuticals Lead Formulation Scientist Ping Wee presented “Optimizing Ocular Gene Therapy: Harnessing the Potential of the Proteolipid Vehicle Nucleic Acid Delivery Platform” in this morning’s poster session. We met new and old friends and made many new connections at ARVO 2024 - DM the team to continue the conversation! #ARVO2024 #EntosSpeaks #Fusogenix #PLV #geneticmedicines #visionhealth #eyehealth

ASGCT update - Amirali Bukhari successfully presented "Optimization of Fusogenix Proteolipid Vehicles for Extra-Hepatic Delivery of mRNA" in the Exhibit Hall, POSTER 765 yesterday. Today at 3:45 - 4:00 pm ET, Room 314-317, Arun Raturi will present "Durable DNA-Based Gene Therapy Using the Non-Viral Fusogenix Proteolipid Vehicle Platform". DM the Entos Pharmaceuticals team; Arun Raturi, Jitendra Kumar, PraKash Bhandari, Douglas Brown, or Amirali Bukhari to discuss the next generation of non-viral delivery! #ASGCT2024 #EntosSpeaks #Fusogenix #PLV #geneticmedicines #genetherapy

We are excited to head to Boston May 14-17 for Informa’s hybrid conference: TIDES USA and Oligonucleotide & Peptide Therapeutics. One of the largest and most renowned events for innovative scientists and industry experts in peptide, oligonucleotide, mRNA, and genome editing fields. Our CEO John Lewis will deliver a presentation on Thursday, May 16 at 2:30 pm, titled Ushering in a New Era of Genetic Medicines with the Fusogenix Proteo-Lipid Vehicle Drug Delivery Platform. We'd love to connect with other attendees - drop John Lewis or CSO Arun Raturi a DM to meet to talk about the next generation of non-viral delivery! #TIDESUSA #OligonucleotidePeptideTherapeutics #EntosSpeaks #Fusogenix #PLVs #nucleicaciddelivery #geneticmedicines

Team Entos Pharmaceuticals is at ASGCT! Today, Douglas Brown presented "Optimizing Ocular Gene Therapy: Harnessing the Potential of the Proteolipid Vehicle Nucleic Acid Delivery Platform" in the ORAL ABSTRACT SESSION B6 - Ophthalmic and Auditory Diseases. Amirali Bukhari is presenting "Optimization of Fusogenix Proteolipid Vehicles for Extra-Hepatic Delivery of mRNA" in the Exhibit Hall, POSTER 765 in SESSION E2. Mark your calendars for May 9 at 3:45 - 4:00 PM ET, Room 314-317, ORAL ABSTRACT SESSION E2, Arun Raturi will present "Durable DNA-Based Gene Therapy Using the Non-Viral Fusogenix Proteolipid Vehicle Platform". DM John Lewis, Arun Raturi, Jitendra Kumar, PraKash Bhandari, Douglas Brown, or Amirali Bukhari to connect and discuss genetic medicine delivery! #ASGCT2024 #EntosSpeaks #Fusogenix #PLV #geneticmedicines #genetherapy

Thank you to The CBRF PRAIRIE Hub for Pandemic Preparedness, Lorne Babiuk, and Ksenia Rybkina for organizing the one-day networking session SPPARCing Connections Outside of Academia. Hearing Christopher Procyshyn's keynote address about Canada's vaccine preparation during the pandemic was very interesting! We also chatted with many highly skilled academic trainees about transitioning and working in industry. #careers #lifesciences #biomanufacturing #EntosSpeaks #geneticmedicines

Day 2 of ARVO - the Entos Pharmaceuticals team is here! Lead Formulation Scientist, Ping Wee, is presenting in the 8 - 9:45 am poster session on May 9: Optimizing Ocular Gene Therapy: Harnessing the Potential of the Proteolipid Vehicle Nucleic Acid Delivery Platform. DM John Lewis, Jason Ding, FCPA, FCA, Jailal Ablack, Liliya Grin, Natasha Govindasamy, Ivana Machado, or Matthew Shin, Ph.D. to continue the conversation! #ARVO2024 #EntosSpeaks #Fusogenix #PLV #geneticmedicines #visionhealth #eyehealth

Today! Entos Pharmaceuticals is at SPP-ARCing Connections Outside of Academia with The CBRF PRAIRIE Hub for Pandemic Preparedness at the University of Alberta. We're looking forward to connecting with trainees to explore career paths in the biotech industry. DM Swapnil Ballal or Perrin Beatty to chat further. Learn more about the event at https://lnkd.in/gjTm-Zzx. #careers #lifesciences #biomanufacturing #EntosSpeaks #geneticmedicines